Trial · NCT04605159
Trial comparisons21
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 20 of 21
Download this page as JSON| Comparison | Source |
|---|---|
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With at Least One MAE From Birth to Day 366 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With RSV-associated Hospitalizations From Birth to Day 181 Post-birth | Trial comparisons |
| RSV MAT Group - Mother vs Placebo Group - Mother: Number of Maternal Participants With at Least One AE Leading to Study Withdrawal From Day 1 to Day 181 Post-delivery | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With All-cause LRTIs With Hospitalization From Birth to Day 181 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With Medically Assessed, RSV-associated LRTIs of Any Severity From Birth to Day 121 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With Medically Assessed, RSV-associated Severe LRTIs From Birth to Day 121 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With at Least One Serious Adverse Event (SAE) From Birth to Day 181 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With All-cause Pneumonia From Birth to Day 181 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With All-cause LRTIs From Birth to Day 181 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With at Least One Adverse Event (AE) Leading to Study Withdrawal From Birth to Day 181 Post-birth | Trial comparisons |
RSV MAT Group - Mother vs Placebo Group - Mother: Number of Maternal Participants With RSV-associated Medically Attended RTIs (RSV-MA-RTIs) From Study Intervention Administration (Day 1) to Day 181 Post-delivery | Trial comparisons |
| RSV MAT Group - Mother vs Placebo Group - Mother: Number of Maternal Participants With Any Unsolicited AEs From Day 1 to Day 30 Included | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With at Least One AE Leading to Study Withdrawal From Birth to Day 366 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With at Least One SAE From Birth to Day 366 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With Medically Assessed, RSV-associated Severe LRTIs From Birth to Day 366 Post-birth | Trial comparisons |
| RSV MAT Group - Mother vs Placebo Group - Mother: Number of Maternal Participants With at Least One MAE From Day 1 to Day 42 Post-delivery | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With Medically Assessed, RSV-associated LRTIs of Any Severity From Birth to Day 366 Post-birth | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With at Least One Medically Attended AE (MAE) From Birth to Day 181 Post-birth | Trial comparisons |
| RSV MAT Group - Mother vs Placebo Group - Mother: Number of Maternal Participants With at Least One All-cause MA-RTI From Day 1 to Day 181 Post-delivery | Trial comparisons |
| RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With RSV-associated Hospitalizations From Birth to Day 366 Post-birth | Trial comparisons |
trials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04605159/comparisons